DE:0T20 / Traws Pharma, Inc. - Net Long/Short Value

Traws Pharma, Inc.
DE ˙ DB
DE:0T20 / Traws Pharma, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Palumbo Wealth Management LLC
Ikarian Capital, LLC
Tower Research Capital LLC (TRC)
Squadron Capital Management LLC
Caitong International Asset Management Co., Ltd
Two Sigma Investments, Lp
BlackRock, Inc.
Adage Capital Partners Gp, L.l.c.
UBS Group AG
Lynx1 Capital Management LP
SBI Securities Co., Ltd.
Geode Capital Management, Llc
Northwestern Mutual Wealth Management Co
State Street Corp
Jane Street Group, Llc
ADAR1 Capital Management, LLC
Royal Bank Of Canada
Boothbay Fund Management, Llc
Jones Financial Companies Lllp
Morgan Stanley
Cassaday & Co Wealth Management LLC
Vanguard Capital Management Llc
Vanguard Fiduciary Trust Co
Dauntless Investment Group, LLC
Vanguard Group Inc
Vanguard Global Advisers, LLC
Orbimed Advisors Llc
Fmr Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:TRAW 1,48 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista